Madrigal Pharmaceuticals (MDGL) Non Operating Income (2010 - 2016)
Madrigal Pharmaceuticals' (MDGL) quarterly Non Operating Income came in at $41778.0 in Q3 2016, up 104.54% year-on-year from $20425.1 in Q4 2015, and up 119.88% on a QoQ basis from $19000.0 in Q2 2016.
Madrigal Pharmaceuticals (MDGL) Non Operating Income (2010 - 2016) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 7 years of Non Operating Income data on file, last reported at $41778.0 in Q3 2016.
- On a quarterly basis, Non Operating Income rose 104.54% year-over-year to $41778.0 in Q3 2016; TTM through Sep 2016 was -$172222.0, a 91.59% increase from a year earlier, with the FY2015 full-year figure at -$1.1 million, up 51.99% from the prior year.
- Non Operating Income for Q3 2016 stood at $41778.0, up from $19000.0 in the prior quarter.
- Over the last five years, Non Operating Income for MDGL reached as high as $41778.0 in Q3 2016 and fell as low as -$1.4 million in Q3 2012.
- Historically, Non Operating Income has averaged -$521738.3 across 5 years, with a median of -$486000.0 in 2012.
- Across the five-year window, Non Operating Income plunged 176.94% in 2012 and surged 106.42% in 2016, its largest moves.
- Year by year, Non Operating Income stood at -$420000.0 in 2012, then plunged by 70.95% to -$718000.0 in 2013, then surged by 36.21% to -$458000.0 in 2014, then jumped by 65.94% to -$156000.0 in 2015, then soared by 126.78% to $41778.0 in 2016.
- Per Business Quant data, the three most recent Non Operating Income figures were $41778.0 in Q3 2016, $19000.0 in Q2 2016, and -$77000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Madrigal Pharmaceuticals | 15.79 Bn | 15.56 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 41,778.00 |
| Jun 30, 2016 | 19,000.00 |
| Mar 31, 2016 | -77,000.00 |
| Dec 31, 2015 | -156,000.00 |
| Sep 30, 2015 | -919,805.00 |
| Jun 30, 2015 | -296,000.00 |
| Mar 31, 2015 | -375,000.00 |
| Dec 31, 2014 | -458,000.00 |
| Sep 30, 2014 | -517,000.00 |
| Jun 30, 2014 | -585,000.00 |
| Mar 31, 2014 | -650,000.00 |
| Dec 31, 2013 | -718,000.00 |
| Sep 30, 2013 | -721,000.00 |
| Jun 30, 2013 | -724,000.00 |
| Mar 31, 2013 | -470,000.00 |
| Dec 31, 2012 | -420,000.00 |
| Sep 30, 2012 | -1.43 Mn |
| Jun 30, 2012 | -972,000.00 |
| Mar 31, 2012 | -486,000.00 |
| Dec 31, 2011 | -504,000.00 |